Since the start of 2020, Eli Lilly’s (NYSE: LLY) stock price chart has been straight up and to the right, up 489.81% and ...

Product approvals in regenerative medicine and rare diseases are among the highlights in our recap of recent FDA regulatory decisions.

Major health insurance providers in India — both public and private — exclude sleep disorders from their plans. This coverage ...

Truly, you'll find me snuggled up in my bed whenever the opportunity arises, and I'm always down to go try some delicious new ...

“Today’s approval marks the first drug treatment option for certain patients with obstructive sleep apnea,” said Sally Seymour, M.D., director of the Division of Pulmonology, Allergy, and Critical ...

The obesity medication Zepbound can be used on-label to treat obstructive sleep apnea in adults with obesity, the FDA ...

What many dismiss as a mere nighttime nuisance often signals deeper health issues requiring medical attention. While snoring ...

Poor sleep hygiene can lead to negative health outcomes, but what exactly is sleep hygiene and how can you improve it?

On December 20, 2024, pharmaceutical company Eli Lilly announced that the FDA approved its first and only obstructive sleep ...

WAKE-UP CALL: 104m Indians or 11% of the population suffer from obstructive sleep apnea, according to a 2023 AIIMS study ...

The Food and Drug Administration approved Eli Lilly’s weight-loss drug Zepbound on Dec. 27 to treat sleep apnea, a common but ...

The sleep disorders center at Bradford Regional Medical Center achieved a milestone in patient care by completing over 1,000 ...